Toru Kimura
Direktor/Vorstandsmitglied bei SUMITOMO PHARMA CO., LTD.
Ursprung des Netzwerks ersten Grades von Toru Kimura
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 34 | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
Altavant Sciences, Inc.
Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Toru Kimura
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
NEC CORPORATION | Information Technology Services | Chairman | |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Corporate Officer/Principal | |
ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
TOKIO MARINE HOLDINGS, INC. | Property/Casualty Insurance | Director/Board Member | |
SUMITOMO CHEMICAL CO., LTD. | Chemicals: Specialty | Corporate Officer/Principal | |
IHI CORPORATION | Industrial Machinery | Director/Board Member | |
HOUSE FOODS GROUP INC. | Food: Specialty/Candy | Director/Board Member | |
SEIKO GROUP CORPORATION | Other Consumer Specialties | Director/Board Member | |
THE ROYAL HOTEL, LIMITED | Hotels/Resorts/Cruise lines | Director/Board Member | |
JCR PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Sumitomo Mitsui Banking Corp.
Sumitomo Mitsui Banking Corp. Major BanksFinance Sumitomo Mitsui Banking Corp. engages in the provision of financial services centered on banking. It operates through the following business segments: Wholesale, Retail, International, Market Sales, and Headquarters Management. The Wholesale segment covers business for customers of large and medium-sized companies in Japan. The Retail segment handles business for domestic individuals and SME customers. The International segment comprises of business for overseas Japanese and non-Japanese companies. The Market Sales segment corresponds to financial market business. The Headquarters Management segment includes all other businesses not covered by other segments. The company was founded in April 2001 and is headquartered in Tokyo, Japan. | Major Banks | Director/Board Member | |
The Japan Research Institute Ltd.
The Japan Research Institute Ltd. Miscellaneous Commercial ServicesCommercial Services The Japan Research Institute Ltd. is a 'knowledge engineering' company, a company that offers information services, through the coordinated application of its three functions, that is, information systems, consulting, and think-tank. As a systems integrator, the company offers services in information technology (IT) strategy planning, implementation and outsourcing for a broad range of industries and activities. The company is also active in research of both domestic and foreign economic issues and formation of policy recommendation, as well as consulting in fields, such as corporate strategies and public administrative reform. In addition, the firm provides analyses and surveys for incubation activities in the creation of new markets and industries. Through these operations The Japan Research Institute offers a vision to its customers towards changes in the economic and social environment as well as developments in the IT area. | Miscellaneous Commercial Services | Chairman | |
SEIKO EPSON CORPORATION | Computer Peripherals | Chairman | |
ANGES, INC. | Pharmaceuticals: Generic | Director/Board Member | |
Kyoto Pharmaceutical Industries Ltd.
Kyoto Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Kyoto Pharmaceutical Industries Ltd. engages in pharmaceutical products manufacturing. Its products include pharmaceuticals to regulate high-blood pressure, Ischemic heart disease treatment, digitalis formulation, and constipation remedies. The firm also develops and produces laxatives, anti-flatulence and anti-diarrheal medicines, and decongestants and cold medicines. The company was founded on September 5, 1946 and is headquartered in Kyoto, Japan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Boston College | College/University | Doctorate Degree | |
Campbell University | College/University | Doctorate Degree | |
University of Tokyo | College/University | Graduate Degree Undergraduate Degree | |
University of Science & Technology of China | College/University | Undergraduate Degree | |
Tokyo Institute of Technology | College/University | Doctorate Degree | |
Hiroshima University | College/University | Doctorate Degree | |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | President | |
JAPAN POST INSURANCE CO., LTD. | Life/Health Insurance | Director/Board Member | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NEC Asia Pacific Pte Ltd.
NEC Asia Pacific Pte Ltd. Information Technology ServicesTechnology Services NEC Asia Pacific Pte Ltd. provides computer software solutions. Its solutions and services include digital signage, ERP, infrastructure, managed services and outsourcing, RFID, public safety solutions and services, unified communications and virtual PC center. The company was founded in 1977 and is headquartered in Singapore. | Information Technology Services | Chairman | |
RENESAS ELECTRONICS CORPORATION | Semiconductors | Director/Board Member | |
Financial Services Agency | General Government | Corporate Officer/Principal | |
Sumitomo Pharma Animal Health Co., Ltd.
Sumitomo Pharma Animal Health Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Sumitomo Pharma Animal Health Co., Ltd. is a Japanese company that manufactures and supplies pharmaceuticals, food ingredients, food additives, veterinary medicines, and diagnostics. The company is based in Osaka, Japan and was founded in 2010. | Pharmaceuticals: Major | Chief Executive Officer | |
JAPAN EXCHANGE GROUP, INC. | Investment Banks/Brokers | Director/Board Member | |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Meltin MMI KK
Meltin MMI KK Medical SpecialtiesHealth Technology Meltin MMI KK develops bio-signal interface technologies. It offers biosignal processing and cable-driven ststems. The company was founded by Sumio Ito, Masahoro Kasuya and Tatsuya Seki and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
MYOVANT SCIENCES LTD. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Enzyvant, Inc.
Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Executive Officer | |
Pancreas Research Foundation of Japan | Chairman | ||
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Enzyvant Therapeutics GmbH
Enzyvant Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Enzyvant Therapeutics GmbH is a Swiss biotechnology company that focuses on developing treatments for rare diseases. The company is based in Basel, Switzerland. William T. Symonds has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistik
International
Japan | 28 |
Vereinigte Staaten | 17 |
Vereinigtes Königreich | 3 |
Schweiz | 3 |
China | 2 |
Sektoral
Health Technology | 23 |
Consumer Services | 8 |
Finance | 7 |
Commercial Services | 4 |
Electronic Technology | 4 |
Operativ
Director/Board Member | 121 |
Corporate Officer/Principal | 65 |
Independent Dir/Board Member | 30 |
Chief Executive Officer | 20 |
Chairman | 14 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Myrtle Potter | 41 |
Adele Gulfo | 16 |
William T. Symonds | 11 |
Nobuhiro Endo | 10 |
Roger Xie | 10 |
Shigeyuki Nishinaka | 9 |
Masayo Tada | 8 |
Hiroshi Nomura | 8 |
Jack Britts | 7 |
Junsuke Fujii | 6 |
Hiroshi Sato | 6 |
Hidehiko Sato | 6 |
Thomas Hoover | 5 |
Nobuhiko Tamura | 5 |
Saburo Hamanaka | 4 |
- Börse
- Insiders
- Toru Kimura
- Unternehmensverbindungen